High- and low-affinity [3H]desipramine-binding sites in human postmortem brain tissue

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Desipramine is a tricyclic antidepressant that inhibits the reuptake of norepinephrine.
• Understanding the binding characteristics of [3H]desipramine in human brain tissue is crucial for elucidating its mechanism of action and potential therapeutic targets.

Purpose of the Study:

• To characterize the binding of [3H]desipramine to human brain tissue.
• To identify and quantify the binding sites for [3H]desipramine.
• To determine if these binding sites correspond to the norepinephrine transporter.

Main Methods:

• Radioligand binding assays using [3H]desipramine.
• Competition studies with noradrenaline and various reuptake inhibitors (nisoxetine, nortriptyline, citalopram).
• Analysis of binding kinetics, including dissociation constant (Kd) and maximum binding capacity (Bmax).

Main Results:

• [3H]desipramine binding in human frontal cortex and hypothalamus exhibited characteristics consistent with multiple binding sites.
• A high-affinity binding component, sensitive to noradrenaline and specific norepinephrine reuptake inhibitors, was identified.
• This high-affinity binding site showed saturable kinetics with a Bmax of 380 +/- 80 fmol/mg protein and an apparent Kd of 5.1 nM in the hypothalamus.

Conclusions:

• Human brain tissue possesses multiple binding sites for [3H]desipramine.
• The high-affinity, saturable binding component likely represents the norepinephrine transporter.
• [3H]desipramine binding, when specifically defined, provides a valuable tool for studying the norepinephrine transporter in the human brain.